Diabetes
| Glycemia
Diabetes
Glycemia
New data from SELECT: People with overweight or obesity and established CVD
book_2
Source:
ADA 2024 - Symposium
calendar_today
Published on Medfyle:
July 2024
import_contacts
4
min
In this medfyle
SELECT prespecified analyses evaluating the CV effects of semaglutide by baseline glycemia and change in HbA1c in a prespecified analysis of SELECT, as well as whether semaglutide slows progression of glycemia in people with CVD and overweight or obesity but without diabetes.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
©2024 Medfyle. All rights reserved.
Source: SELECT Trial—New Looks at Glycemia, Inflammation, and Heart Failure Symposium. ADA 2024.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.
